SlideShare una empresa de Scribd logo
1 de 65
THROMBOLYSIS IN ACUTE
ISCHEMIC STROKE
Experience at our stroke unit in
2011-2012
DR Sanjay Jaiswal, D.MDR Sanjay Jaiswal, D.M
Member World Stroke OrganizationMember World Stroke Organization
Senior Consultant Neurologist &Senior Consultant Neurologist &
Stroke NeurophysicianStroke Neurophysician
Jaiswal Hospital and Neuro Institute, KOTAJaiswal Hospital and Neuro Institute, KOTA
OutlinesOutlines
 The burden of disease & Stroke FactsThe burden of disease & Stroke Facts
 PathophysiologyPathophysiology
 Stroke mimicsStroke mimics
 Pre thrombolysis work up.Pre thrombolysis work up.
 Safety and efficacy of IVSafety and efficacy of IV t PA .t PA .
 Inclusion and Exclusion criteria's.Inclusion and Exclusion criteria's.
 How Tpa is administered.How Tpa is administered.
 Time frame (Door to needle time)Time frame (Door to needle time)
 Our stroke teamOur stroke team
THE BURDEN OF STROKE
 Anually more than 15 million people world wideAnually more than 15 million people world wide
suffer a stroke, 5.5 million die and 5 million are leftsuffer a stroke, 5.5 million die and 5 million are left
with permanent disability.with permanent disability.
 Stroke is 2nd most common cause of death.Stroke is 2nd most common cause of death.
 In India 1.5million people suffer from Acute StrokeIn India 1.5million people suffer from Acute Stroke
every year.every year.
 1880 people die every day in India due to1880 people die every day in India due to
strokestroke
 World wide some one dies of stroke every 6World wide some one dies of stroke every 6
seconds.seconds.
 Every two second some one some where inEvery two second some one some where in
world suffers from stroke.world suffers from stroke.
 Stroke kills more people each year than AIDS,Stroke kills more people each year than AIDS,
TB, and Malaria put together.TB, and Malaria put together.
 Incidence of stroke is increasing in India andIncidence of stroke is increasing in India and
other developing countriesother developing countries
Stroke Facts
 80 % of strokes are Ischemic .80 % of strokes are Ischemic .
 Only 15 % of stroke patients reach inOnly 15 % of stroke patients reach in
hospital within 3 hrs.hospital within 3 hrs.
 1-5% are thrombolysed1-5% are thrombolysed
Reasons for lack of thrombolysis
1. Patient’s inability to recognize stroke symptoms.
 40% of stroke patients can’t name a single symptom40% of stroke patients can’t name a single symptom
of stroke.of stroke.
 85% of patients believe that their symptoms are not85% of patients believe that their symptoms are not
serious enough to seek urgent treatment.serious enough to seek urgent treatment.
2. Physician’s lack of experience with stroke
thrombolysis and therefore reluctance to “risk”
treatment
3. Lack of organized delivery of care in most of the
medical centers throughout the country.
Nandigram et al 2003
 Observed lack of knowledge regarding strokeObserved lack of knowledge regarding stroke
thrombolysis among medical professionals inthrombolysis among medical professionals in
india.india.
 Significant majority of the GPs were not awareSignificant majority of the GPs were not aware
of the beneficial effects of thrombolysis.of the beneficial effects of thrombolysis.
CASE 1CASE 1
 76 Yr old Retired Head Master, relative of a doctor.76 Yr old Retired Head Master, relative of a doctor.
 No H/O HTN, DM,CADNo H/O HTN, DM,CAD
 Presented with H/O Acute onset Rt hemiparesis withPresented with H/O Acute onset Rt hemiparesis with
difficulty in walking independently at 6.30 PM ,wasdifficulty in walking independently at 6.30 PM ,was
brought on wheel chair.brought on wheel chair.
 Reached to our hospital at 7.50 PM.Reached to our hospital at 7.50 PM.
 CT head –No e/o hemorrhage ,haematological investCT head –No e/o hemorrhage ,haematological invest
done. Clinical work up completed. by 9.00 PM.done. Clinical work up completed. by 9.00 PM.
 Consent received at 10 .00 PM ( 1 hour wasted byConsent received at 10 .00 PM ( 1 hour wasted by
relatives in giving consent )relatives in giving consent )
 Thrombolysis started at 10.00 PMThrombolysis started at 10.00 PM
 Motor power started improving during thrombolysis.Motor power started improving during thrombolysis.
 In 24 hrs pt was able to walk with little support.In 24 hrs pt was able to walk with little support.
 Discharged on 6 day with mild Neurodeficit.Discharged on 6 day with mild Neurodeficit.
 A doctor who is relative of the patient playedA doctor who is relative of the patient played
important role in explaining beneficial effects ofimportant role in explaining beneficial effects of
thrombolysisthrombolysis
CASE 2
 76 Yr old male F/O a Doctor had stroke.76 Yr old male F/O a Doctor had stroke.
 At 8.30 AM had left sided weakness with slurred speech and confusedAt 8.30 AM had left sided weakness with slurred speech and confused
state ,not able to walk.state ,not able to walk.
 Brought into hospital at 9.30 AM.Brought into hospital at 9.30 AM.
 Pt wheeled straight into CT scan.Pt wheeled straight into CT scan.
 Pt shifted to stroke unit, IV Line started and blood withdrawn.Pt shifted to stroke unit, IV Line started and blood withdrawn.
 k/c HT, CAD, H/O Angioplasty 15 yrs ago, on anti HT +k/c HT, CAD, H/O Angioplasty 15 yrs ago, on anti HT +
ASAASA.(missed ASA for 2 days).(missed ASA for 2 days)
 Lt UL– Lifting against gravity but weak grip.Lt UL– Lifting against gravity but weak grip.
 Lt LL –2- /5, not able to walk independentlyLt LL –2- /5, not able to walk independently
 Poor comprehension with dysarthriaPoor comprehension with dysarthria
 CT--. No hemorrhage seenCT--. No hemorrhage seen
 BP---140/80BP---140/80
 RBS– 118 MG%, CBC, PT , APTT- Normal.RBS– 118 MG%, CBC, PT , APTT- Normal.
 Option of thrombolysis given to his son.Option of thrombolysis given to his son.
 Consent for tPA taken.Consent for tPA taken.
 IV tPA started at 11.30 am. (stroke to needle time 3 hrs)IV tPA started at 11.30 am. (stroke to needle time 3 hrs)
 By the time infusion was finished , pt became alert and hisBy the time infusion was finished , pt became alert and his
motor power improved significantly.motor power improved significantly.
 By evening (6 hrs post thrombolysis) pt. was walkingBy evening (6 hrs post thrombolysis) pt. was walking
independently and and had normal speech.independently and and had normal speech.
 Discharged on 3Discharged on 3rdrd
day with no neurodeficit, WITHday with no neurodeficit, WITH
COMPLETE RECOVERY.COMPLETE RECOVERY.
CASE 3CASE 3
 68 Yr old male,68 Yr old male,
 k/c HT, CAD, h/o CABG 10 yrs ago, on anti HT + ASA.k/c HT, CAD, h/o CABG 10 yrs ago, on anti HT + ASA.
 At 9.30 PM had right sided weakness with slurred speech .At 9.30 PM had right sided weakness with slurred speech .
 Rt L/L Power 1-2 /5, Rt UL 3/5, dysarthria+Rt L/L Power 1-2 /5, Rt UL 3/5, dysarthria+
 Brought into hospital at 11.00 PM.Brought into hospital at 11.00 PM.
 Pt shifted to stroke unit, IV Line started and blood withdrawn.Pt shifted to stroke unit, IV Line started and blood withdrawn.
 CT scan head showed no e/o haemorrhage.CT scan head showed no e/o haemorrhage.
 Consent for tPA takenConsent for tPA taken
 IV- tPA started at 12.30 AM. (stroke to needle
time 3 hrs.
 During the infusion pt started moving Rt leg.
and his grip had improved significantly.
 By next morning (6 hrs post thrombolysis) pt
was walking independantly and with no
dysarthria.
 Patient discharged without any neurodeficit.
PathophysiologyPathophysiology
2 Million Neurones are lost every minute
in the period in which stroke is untreated
PathophysiologyPathophysiology
 ischemic penumbraischemic penumbra is the area of the brainis the area of the brain
surrounding the infarcted core,and is preservedsurrounding the infarcted core,and is preserved
by a tenacious supply of blood from collateralby a tenacious supply of blood from collateral
vessels.vessels.
 This area can be rescued if the occludedThis area can be rescued if the occluded
vessel can be reopened up to 3-8 hours fromvessel can be reopened up to 3-8 hours from
symptom onsetsymptom onset
Cerebral infarct <3hrsCerebral infarct <3hrs
Onset
Infarct
Ischaemic
penumbra
Cerebral infarct 6hrsCerebral infarct 6hrs
Infarct
Ischaemic
penumbra
Cerebral infarct 24hrsCerebral infarct 24hrs
Infarct
Ischaemic
penumbra
Penumbrae of Ischemic
Stroke  Penumbrae is the target of
any reperfusion therapy
 The fate of brain tissue
depends on
 Time
 Cerebral blood flow
 Occluded arterial flow
 Collateral blood flow
 Time is brain-We have to
act fast to rescue the
Penumbrae
Stroke MimicsStroke Mimics
 SyncopeSyncope
 Partial epileptic seizurePartial epileptic seizure
with Todd’s paresiswith Todd’s paresis
 Migraine attack (aura)Migraine attack (aura)
 HypoglycaemiaHypoglycaemia
 HysteriaHysteria
 IntoxicationIntoxication
 HypertensiveHypertensive
encephalopathyencephalopathy
 SubarachnoidSubarachnoid
haemorrhagehaemorrhage
 NeuroinfectionNeuroinfection
 NeoplasmNeoplasm
 Chr SDHChr SDH
 Multiple sclerosisMultiple sclerosis
 Peripheral vertigoPeripheral vertigo
Hyperacute Stroke: Modern
Approach of Tt
 Aim: Revascularization of penumbraAim: Revascularization of penumbra 
Break down Clot!Break down Clot!
 Methods: IV, IA, MechanicalMethods: IV, IA, Mechanical
ThrombolysisThrombolysis
 Most practical, with proven efficacy atMost practical, with proven efficacy at
place like KOTA : IV thrombolysis withplace like KOTA : IV thrombolysis with
TPA.TPA.
Time is BrainTime is Brain
Pre thrombolysis work upPre thrombolysis work up
 Should be individualizedShould be individualized
 All Pts must have emergently :All Pts must have emergently :
1.1. NCCT BRAINNCCT BRAIN
2.2. ECGECG
3.3. CBC,Plat count, B groupCBC,Plat count, B group
4.4. B GlucoseB Glucose
5.5. Coagulation-PT with INR,APTTCoagulation-PT with INR,APTT
6.6. Other metabolic tests-RFT, LFT, etcOther metabolic tests-RFT, LFT, etc
NCCT BRAIN
 Initial imaging modality in hyper ac stroke
 Widely available, quick, easy to perform
 Accurately identifies ICH,SAH
EARLY SIGNS OF CEREBRAL ISCHAEMIA
 Hyper dense MCA artery sign
 Hyper dense dot sign
 Hypo density of insular ribbon
 Hypoensity of basal ganglia
 loss of grey white matter differentiation in cortical ribbon
 sulcal effacement
EARLY SIGNS ARE ASSOCIATED WITH POORER OUTCOMES
Left and middle: Hyperdense left MCA sign (yellow arrow), hypoattenuated left basal
ganglia (red arrow), and cortical swelling (blue arrows) in the same patient. Right:
Dot sign (yellow arrow) in the left sylvian fissure.
Early CT signs in acute MCAEarly CT signs in acute MCA
strokestroke
NIHSS SCORENIHSS SCORE
 NIHSS SCORING CAN BE PERFORMEDNIHSS SCORING CAN BE PERFORMED
IN 7 MINUTES .IN 7 MINUTES .
 ESSENTIAL TO BE CALCULATEDESSENTIAL TO BE CALCULATED
PREDICTOR OF STROKE OUTCOME ANDPREDICTOR OF STROKE OUTCOME AND
USED AS A EXCLUSION CRITERIAUSED AS A EXCLUSION CRITERIA ..
Inclusion CriteriaInclusion Criteria
 Clinical signs and symptoms consistent withClinical signs and symptoms consistent with
stroke.stroke.
 Patient last seen normal within 4.5 hrs.Patient last seen normal within 4.5 hrs.
 Measurable neurological deficit.Measurable neurological deficit.
Exclusion Criteria
 Any hemorrhage on neuroimaging.Any hemorrhage on neuroimaging.
 Symptoms s/o SAH.Symptoms s/o SAH.
 Seizure at stroke onset with post ictal neurol deficit.Seizure at stroke onset with post ictal neurol deficit.
 Hypodensity greater than 1/3 cerebral hemisphere onHypodensity greater than 1/3 cerebral hemisphere on
CT.CT.
 SBP>185 & DBP>110SBP>185 & DBP>110
 RBS <50 or > 400 mg%RBS <50 or > 400 mg%
 Stroke with major neurol deficits-NIHS >22.Stroke with major neurol deficits-NIHS >22.
 Minor/isolated/spontaneously clearing neurol signs.Minor/isolated/spontaneously clearing neurol signs.
Exclusion Criteria
 Platelet count <1 lac/mm3Platelet count <1 lac/mm3
 INR>1.7INR>1.7
 Elevated APTT.Elevated APTT.
 Past h/o ICHPast h/o ICH
 Arterial puncture at non compressible site in 7 days.Arterial puncture at non compressible site in 7 days.
 Major surgery in past 14 days.Major surgery in past 14 days.
 GI bleed or hematuria in past 21 days.GI bleed or hematuria in past 21 days.
 Ischemic stroke, Myocardial infarction or serious headIschemic stroke, Myocardial infarction or serious head
trauma in last 3 months.trauma in last 3 months.
 Evidence of active bleeding or ac trauma (fracture onEvidence of active bleeding or ac trauma (fracture on
exam).exam).
Stroke Thrombolysis at 3-4.5 Hrs
additional Exclusion Criterias
 Age >80 yearsAge >80 years
 On oral anticoagulants regardless of INROn oral anticoagulants regardless of INR
 NIHSS of >25 (Severe stroke)NIHSS of >25 (Severe stroke)
 History of both stroke and diabetes.History of both stroke and diabetes.
I.VI.V t PAt PA :: Safety and efficacySafety and efficacy
Evidence for tPA < 3Evidence for tPA < 3
HoursHours
NINDS t PA stroke trial(1995)
 NEJM 95:333,1581-87NEJM 95:333,1581-87
 624 patients randomized624 patients randomized
 3 hour window3 hour window
At three months 30% more likelyAt three months 30% more likely
to have minimal or no disabilityto have minimal or no disability
 6.4% risk of hemorrhage6.4% risk of hemorrhage
NINDS tPA Stroke Trial
0
10
20
30
0
10
20
30
tPA tPAPlacebo Placebo
31
20 9
8
20
1
NIHSS Excellent
Recovery (%)
Total Death
Rate (%)
Hemorrhage
p < .05
New England Journal, 1995
NINDS TPA Stroke Trial
Global outcome statistic: OR=1.7, 50% v. 38%= 12% benefit
Excellent outcome at 3 months on all scales
52%
38%
43%
26%
45%
31%
34%
21%
0%
10%
20%
30%
40%
50%
60%
Barthel
Index
Rankin
Scale
Glasgow
Outcome
NIHSS
score
TPA
Placebo
N Engl J Med 1995;333:1581-7
Time is brain( EARLIER THE BETTER) benefit from rt-
PA declines with increasing delay from onset to
treatment time
Benefit
Harm
3 hours 6 hours
Upper and lower 95% confidence limits
Line of no effect
IST-3 protocol
For every 100 patients treated withFor every 100 patients treated with t PAt PA ,,
32 benefit, 3 harmed32 benefit, 3 harmed
Saver JL et al , Stroke 2007; 38:2279-2283
better outcome by 1 or more grades on the mRS
Stroke Thrombolysis:
Thrombolytic therapy must be given byThrombolytic therapy must be given by
an experienced physicianan experienced physician after theafter the
imaging of the brain is assessed byimaging of the brain is assessed by
physicians experienced in reading thephysicians experienced in reading the
imaging studyimaging study22
1: Hacke W et al.: Lancet (2004) 363:768-74
2: Wahlgren N et al.: Lancet (2007) 369:275-82
Stroke Thrombolysis:Stroke Thrombolysis:
Evidence forEvidence for t PAt PA at 3 – 4.5at 3 – 4.5
hrshrs
Time is Brain :Time is Brain : NINDS Recommended Stroke EvaluationNINDS Recommended Stroke Evaluation
Targets for Potential Thrombolytic CandidatesTargets for Potential Thrombolytic Candidates
Target time framesTarget time frames
Door to doctorDoor to doctor 10 minutes10 minutes
Door to CT completionDoor to CT completion 25 minutes25 minutes
Door to CT readingDoor to CT reading 45 minutes45 minutes
Door to drug treatmentDoor to drug treatment 60 minutes60 minutes
How to administer IV t PA
 Infuse 0.9mg/kg(max 90 mg ) over 60 mnts with 10 % ofInfuse 0.9mg/kg(max 90 mg ) over 60 mnts with 10 % of
the dose given as bolus over 1 mnt.the dose given as bolus over 1 mnt.
 Admit pt in neuro ICU or stroke unit.Admit pt in neuro ICU or stroke unit.
 Perform neurological assessment every 15 mnts duringPerform neurological assessment every 15 mnts during
the infusion and every 30 mnts thereafter for next 6 hoursthe infusion and every 30 mnts thereafter for next 6 hours
then hourly until 24 hours after treatment.then hourly until 24 hours after treatment.
 If pt develop severe headache,ac HTN, nausea,orIf pt develop severe headache,ac HTN, nausea,or
vomitting discontinue infusion and obtain emergency CTvomitting discontinue infusion and obtain emergency CT
scan.scan.
 AngioedemaAngioedema
Risk of hemorrhagic
transformation
 MarkedMarked
hyperglycemia orhyperglycemia or
DMDM
 CT >1/3CT >1/3 cerebralcerebral
hemispherehemisphere
 Increasing strokeIncreasing stroke
severityseverity
 Low platelet countsLow platelet counts
 Higher NIHSS scoreHigher NIHSS score
 Longer time toLonger time to
recanalizationrecanalization
~ Stroke. 2002~ Stroke. 2002
If intracranial hemorrhage present:
 Obtain fibrinogen results.Obtain fibrinogen results.
 Prepare for administration of 6 to 8 units of cryoprecipitatePrepare for administration of 6 to 8 units of cryoprecipitate
containing factor VIII.containing factor VIII.
 Prepare for administration of 6 to 8 units of platelets.Prepare for administration of 6 to 8 units of platelets.
 Consider alerting and consulting a hematologist orConsider alerting and consulting a hematologist or
neurosurgeon.neurosurgeon.
 Consider decision regarding further medical and/or surgicalConsider decision regarding further medical and/or surgical
therapy.therapy.
 Consider second CT to assess progression of intracranialConsider second CT to assess progression of intracranial
hemorrhage.hemorrhage.
 A plan for access to emergent neurosurgical consultation isA plan for access to emergent neurosurgical consultation is
highly recommended.highly recommended.
Acute Ischemic Stroke Protocol
ER arrival
Triage nurse confirm stroke onset time < 4.5 hours
ER Resident performs
Rapid evaluation (5 minutes)
1.exact time of onset
2.important history
3.quick neurological evaluation
STAT CT and blood work
Neurology Resident receives
ER stroke page and
proceeds to ER
brief history & physical exam
Page Stroke consultant
Head CT findings, laboratory data, NIH stroke scale
Confirm the criteria fulfilling thrombolytic therapy for ischemic stroke
Family’s agreement for thrombolytic therapy
Stroke onset < 4.5 hours
IV-tPA treatment
Patient is admitted to Stroke ICU for intensive monitoring/care
Stroke onset 4.5-8 hours
IA t therapy /device
Call Neuroradiologists
IA thrombolysis/device
 11STST
Case tPA given in 3.30 hrs.Case tPA given in 3.30 hrs.
 22ndnd
Case tPA given in 3 hrs.Case tPA given in 3 hrs.
 33rdrd
Case tPA given in 3 hrsCase tPA given in 3 hrs
 All made excellent recovery.All made excellent recovery.
 Earlier protocol ---Earlier protocol ---
window period -- 3hrs.window period -- 3hrs.
 Latest ECASS 3 trial---Latest ECASS 3 trial---
window period extended upto 4.5 hrs.window period extended upto 4.5 hrs.
OUR STROKE TEAM
 NeurologistNeurologist
 NeurosurgeonNeurosurgeon
 IntensivistIntensivist
 NeuroradiologistNeuroradiologist
 NeuropathologistNeuropathologist
 NeurophysiotherepistNeurophysiotherepist
 RMOS,Techs,Trained staffRMOS,Techs,Trained staff
TAKE HOME MESSAGE
 IV r TPA IS RECOMMENDEDIV r TPA IS RECOMMENDED
THEREPY FOR SELECTED PATIENTSTHEREPY FOR SELECTED PATIENTS
WHO REACH HOSPITAL WITHIN 4.5WHO REACH HOSPITAL WITHIN 4.5
HOURS OF STROKE ONSET.HOURS OF STROKE ONSET.
 Thrombolysis is possible in kota.Thrombolysis is possible in kota.
 Need to rush from bed to bedside.Need to rush from bed to bedside.
TAKE HOME MESSAGETAKE HOME MESSAGE
 At 3 months 30% more likely to have minimalAt 3 months 30% more likely to have minimal
or no disability following thrombolysis.or no disability following thrombolysis.
 There should be no protocol violation otherThere should be no protocol violation other
wise more complications.wise more complications.
 We have to increase awareness among patients,We have to increase awareness among patients,
general public and doctors regarding beneficialgeneral public and doctors regarding beneficial
effects of stroke thrombolysis.effects of stroke thrombolysis.
World Stroke day- 29 octoberWorld Stroke day- 29 october
WSO Slogan- entitled ‘Because I care..WSO Slogan- entitled ‘Because I care..
Because I care…
I want you to know the facts about stroke
I want you to learn how to prevent the assault of stroke
I will break the myths surrounding stroke, e.g., “stroke only happens later in
life”
I want you to have access to the best possible
treatment
I will ensure that you receive quality treatment, care
and support
I will be with you every step of the way towards your full
recovery
THANK YOUTHANK YOU

Más contenido relacionado

La actualidad más candente

Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury [PSH in TBI]
Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury [PSH in TBI]Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury [PSH in TBI]
Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury [PSH in TBI]Dhaval Shukla
 
Thrombectomy for ischemic stroke and anaesthesia
Thrombectomy for ischemic stroke and anaesthesiaThrombectomy for ischemic stroke and anaesthesia
Thrombectomy for ischemic stroke and anaesthesiaWahid altaf Sheeba hakak
 
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?ahvc0858
 
Thrombolytic therqapy in stroke 14.2.01
Thrombolytic therqapy in stroke 14.2.01Thrombolytic therqapy in stroke 14.2.01
Thrombolytic therqapy in stroke 14.2.01PS Deb
 
Cerebral venous sinus thrombosis
Cerebral venous sinus thrombosisCerebral venous sinus thrombosis
Cerebral venous sinus thrombosisSiva Pesala
 
THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....
THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....
THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....Arlyn Valencia, M.D.
 
Localization of MI on ECG
Localization of MI on ECGLocalization of MI on ECG
Localization of MI on ECGNooh Khushal
 
Primary Percutaneus coronary intervention
Primary Percutaneus coronary interventionPrimary Percutaneus coronary intervention
Primary Percutaneus coronary interventionRamachandra Barik
 
Role of anticoagulation in neurocritical care jhjk
Role of anticoagulation in   neurocritical care jhjkRole of anticoagulation in   neurocritical care jhjk
Role of anticoagulation in neurocritical care jhjkAnkit Gajjar
 
2018 AHA ASA guideline - guidelines for the early management of patients with...
2018 AHA ASA guideline - guidelines for the early management of patients with...2018 AHA ASA guideline - guidelines for the early management of patients with...
2018 AHA ASA guideline - guidelines for the early management of patients with...Vinh Pham Nguyen
 
AHA/ASA Guidelines for Ischemic Stroke
AHA/ASA Guidelines for Ischemic StrokeAHA/ASA Guidelines for Ischemic Stroke
AHA/ASA Guidelines for Ischemic StrokeSun Yai-Cheng
 
Management of acute ischemic stroke
Management of acute ischemic strokeManagement of acute ischemic stroke
Management of acute ischemic strokeSudhir Kumar
 
Damage Control Resuscitation
Damage Control ResuscitationDamage Control Resuscitation
Damage Control ResuscitationSun Yai-Cheng
 
Prehospital Stroke Care
Prehospital Stroke Care Prehospital Stroke Care
Prehospital Stroke Care Ade Wijaya
 
Damage control resuscitation
Damage control resuscitationDamage control resuscitation
Damage control resuscitationSCGH ED CME
 
Management of Surgical Patients Receiving Anticoagulation and Antiplatelet Ag...
Management of Surgical Patients Receiving Anticoagulation and Antiplatelet Ag...Management of Surgical Patients Receiving Anticoagulation and Antiplatelet Ag...
Management of Surgical Patients Receiving Anticoagulation and Antiplatelet Ag...Ade Wijaya
 

La actualidad más candente (20)

Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury [PSH in TBI]
Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury [PSH in TBI]Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury [PSH in TBI]
Paroxysmal Sympathetic Hyperactivity in Traumatic Brain Injury [PSH in TBI]
 
Thrombectomy for ischemic stroke and anaesthesia
Thrombectomy for ischemic stroke and anaesthesiaThrombectomy for ischemic stroke and anaesthesia
Thrombectomy for ischemic stroke and anaesthesia
 
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
 
Thrombolytic therqapy in stroke 14.2.01
Thrombolytic therqapy in stroke 14.2.01Thrombolytic therqapy in stroke 14.2.01
Thrombolytic therqapy in stroke 14.2.01
 
Cerebral venous sinus thrombosis
Cerebral venous sinus thrombosisCerebral venous sinus thrombosis
Cerebral venous sinus thrombosis
 
THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....
THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....
THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....
 
Localization of MI on ECG
Localization of MI on ECGLocalization of MI on ECG
Localization of MI on ECG
 
Primary Percutaneus coronary intervention
Primary Percutaneus coronary interventionPrimary Percutaneus coronary intervention
Primary Percutaneus coronary intervention
 
Acute stroke 2019
Acute stroke 2019Acute stroke 2019
Acute stroke 2019
 
Role of anticoagulation in neurocritical care jhjk
Role of anticoagulation in   neurocritical care jhjkRole of anticoagulation in   neurocritical care jhjk
Role of anticoagulation in neurocritical care jhjk
 
2018 AHA ASA guideline - guidelines for the early management of patients with...
2018 AHA ASA guideline - guidelines for the early management of patients with...2018 AHA ASA guideline - guidelines for the early management of patients with...
2018 AHA ASA guideline - guidelines for the early management of patients with...
 
AHA/ASA Guidelines for Ischemic Stroke
AHA/ASA Guidelines for Ischemic StrokeAHA/ASA Guidelines for Ischemic Stroke
AHA/ASA Guidelines for Ischemic Stroke
 
Management of acute ischemic stroke
Management of acute ischemic strokeManagement of acute ischemic stroke
Management of acute ischemic stroke
 
Damage Control Resuscitation
Damage Control ResuscitationDamage Control Resuscitation
Damage Control Resuscitation
 
Prehospital Stroke Care
Prehospital Stroke Care Prehospital Stroke Care
Prehospital Stroke Care
 
ATLS- Advanced Trauma Life Support
ATLS- Advanced Trauma Life SupportATLS- Advanced Trauma Life Support
ATLS- Advanced Trauma Life Support
 
Damage control resuscitation
Damage control resuscitationDamage control resuscitation
Damage control resuscitation
 
Management of Surgical Patients Receiving Anticoagulation and Antiplatelet Ag...
Management of Surgical Patients Receiving Anticoagulation and Antiplatelet Ag...Management of Surgical Patients Receiving Anticoagulation and Antiplatelet Ag...
Management of Surgical Patients Receiving Anticoagulation and Antiplatelet Ag...
 
Eras fast track surgery
Eras fast track surgeryEras fast track surgery
Eras fast track surgery
 
INTERESTING ECGS
INTERESTING ECGSINTERESTING ECGS
INTERESTING ECGS
 

Destacado

What is a stent retreiver
What is a stent retreiverWhat is a stent retreiver
What is a stent retreiverAllan Tan
 
IVtPA vs Mechanical thrombolysis, after 3-hours of stroke
IVtPA vs Mechanical thrombolysis, after 3-hours of strokeIVtPA vs Mechanical thrombolysis, after 3-hours of stroke
IVtPA vs Mechanical thrombolysis, after 3-hours of strokeDr Vipul Gupta
 
Push and Puff Technique for Mechanical Thrombectomy
Push and Puff Technique for Mechanical ThrombectomyPush and Puff Technique for Mechanical Thrombectomy
Push and Puff Technique for Mechanical ThrombectomyDr Vipul Gupta
 
Endovascular Introduction
Endovascular IntroductionEndovascular Introduction
Endovascular IntroductionAlvin Wang
 
Recent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysisRecent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysisDr Vipul Gupta
 

Destacado (6)

What is a stent retreiver
What is a stent retreiverWhat is a stent retreiver
What is a stent retreiver
 
IVtPA vs Mechanical thrombolysis, after 3-hours of stroke
IVtPA vs Mechanical thrombolysis, after 3-hours of strokeIVtPA vs Mechanical thrombolysis, after 3-hours of stroke
IVtPA vs Mechanical thrombolysis, after 3-hours of stroke
 
Push and Puff Technique for Mechanical Thrombectomy
Push and Puff Technique for Mechanical ThrombectomyPush and Puff Technique for Mechanical Thrombectomy
Push and Puff Technique for Mechanical Thrombectomy
 
Endovascular Prep Basic
Endovascular Prep BasicEndovascular Prep Basic
Endovascular Prep Basic
 
Endovascular Introduction
Endovascular IntroductionEndovascular Introduction
Endovascular Introduction
 
Recent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysisRecent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysis
 

Similar a Stroke thrombolysis Dr Sanjay Jaiswal,consultant nerologist,Jaiswal Hospital and neuro institute,kota,Rajasthan,India

Ventricular septum rupture after awmi By Dr. Haseeb Raza Naqvi
Ventricular septum rupture after awmi By Dr. Haseeb Raza NaqviVentricular septum rupture after awmi By Dr. Haseeb Raza Naqvi
Ventricular septum rupture after awmi By Dr. Haseeb Raza Naqviauditoriummic
 
Stroke - Cerebrovascular Accident - (CVA)
Stroke - Cerebrovascular Accident - (CVA)Stroke - Cerebrovascular Accident - (CVA)
Stroke - Cerebrovascular Accident - (CVA)steveclaydon1970
 
Wpw case presentation by dr adeel
Wpw case presentation by dr adeelWpw case presentation by dr adeel
Wpw case presentation by dr adeelWest Medicine Ward
 
ECG evaluation by history and tracings -1
ECG  evaluation by history and tracings -1ECG  evaluation by history and tracings -1
ECG evaluation by history and tracings -1Toufiqur Rahman
 
Med viva/revision for Anaes M.Med Part 2
Med viva/revision for Anaes M.Med Part 2 Med viva/revision for Anaes M.Med Part 2
Med viva/revision for Anaes M.Med Part 2 Hon Liang
 
Palpitations (dr. j dwight)
Palpitations (dr. j dwight)Palpitations (dr. j dwight)
Palpitations (dr. j dwight)Phchevalier
 
Neuro clinics 21- stroke case discussion
Neuro clinics 21- stroke case discussionNeuro clinics 21- stroke case discussion
Neuro clinics 21- stroke case discussionPratyush Chaudhuri
 
Basics of stroke(CVA) Management
Basics of stroke(CVA) ManagementBasics of stroke(CVA) Management
Basics of stroke(CVA) ManagementDr Ashutosh Ojha
 
Transcatheter Aortic Valve Replacement (TAVR): Established and Emerging Indic...
Transcatheter Aortic Valve Replacement (TAVR): Established and Emerging Indic...Transcatheter Aortic Valve Replacement (TAVR): Established and Emerging Indic...
Transcatheter Aortic Valve Replacement (TAVR): Established and Emerging Indic...Allina Health
 
Initial approach to trauma
Initial approach to traumaInitial approach to trauma
Initial approach to traumaShankar Hippargi
 
Clinical Neurosciences Networking Seminar
Clinical Neurosciences Networking SeminarClinical Neurosciences Networking Seminar
Clinical Neurosciences Networking SeminarCraftyDesigner
 
acute stroke for rehab physician - dr trilochan shrivastava
acute stroke for rehab physician - dr trilochan shrivastavaacute stroke for rehab physician - dr trilochan shrivastava
acute stroke for rehab physician - dr trilochan shrivastavamrinal joshi
 
Hemiplegia stroke
Hemiplegia strokeHemiplegia stroke
Hemiplegia strokethekumar
 
ASSESSMENT AND PLANNING GUIDE FOR USE IN THE HOSPITALThe followi.docx
ASSESSMENT AND PLANNING GUIDE FOR USE IN THE HOSPITALThe followi.docxASSESSMENT AND PLANNING GUIDE FOR USE IN THE HOSPITALThe followi.docx
ASSESSMENT AND PLANNING GUIDE FOR USE IN THE HOSPITALThe followi.docxgalerussel59292
 
MedReg+1 Bhuva ECGs
MedReg+1 Bhuva ECGsMedReg+1 Bhuva ECGs
MedReg+1 Bhuva ECGsMedReg+1
 

Similar a Stroke thrombolysis Dr Sanjay Jaiswal,consultant nerologist,Jaiswal Hospital and neuro institute,kota,Rajasthan,India (20)

Ventricular septum rupture after awmi By Dr. Haseeb Raza Naqvi
Ventricular septum rupture after awmi By Dr. Haseeb Raza NaqviVentricular septum rupture after awmi By Dr. Haseeb Raza Naqvi
Ventricular septum rupture after awmi By Dr. Haseeb Raza Naqvi
 
Loosemore
LoosemoreLoosemore
Loosemore
 
Stroke - Cerebrovascular Accident - (CVA)
Stroke - Cerebrovascular Accident - (CVA)Stroke - Cerebrovascular Accident - (CVA)
Stroke - Cerebrovascular Accident - (CVA)
 
Wpw case presentation by dr adeel
Wpw case presentation by dr adeelWpw case presentation by dr adeel
Wpw case presentation by dr adeel
 
ECG evaluation by history and tracings -1
ECG  evaluation by history and tracings -1ECG  evaluation by history and tracings -1
ECG evaluation by history and tracings -1
 
Med viva/revision for Anaes M.Med Part 2
Med viva/revision for Anaes M.Med Part 2 Med viva/revision for Anaes M.Med Part 2
Med viva/revision for Anaes M.Med Part 2
 
Thrombolysis
ThrombolysisThrombolysis
Thrombolysis
 
Palpitations (dr. j dwight)
Palpitations (dr. j dwight)Palpitations (dr. j dwight)
Palpitations (dr. j dwight)
 
Neuro clinics 21- stroke case discussion
Neuro clinics 21- stroke case discussionNeuro clinics 21- stroke case discussion
Neuro clinics 21- stroke case discussion
 
Basics of stroke(CVA) Management
Basics of stroke(CVA) ManagementBasics of stroke(CVA) Management
Basics of stroke(CVA) Management
 
Transcatheter Aortic Valve Replacement (TAVR): Established and Emerging Indic...
Transcatheter Aortic Valve Replacement (TAVR): Established and Emerging Indic...Transcatheter Aortic Valve Replacement (TAVR): Established and Emerging Indic...
Transcatheter Aortic Valve Replacement (TAVR): Established and Emerging Indic...
 
Initial approach to trauma
Initial approach to traumaInitial approach to trauma
Initial approach to trauma
 
Chronic kidney disease
Chronic kidney diseaseChronic kidney disease
Chronic kidney disease
 
Clinical Neurosciences Networking Seminar
Clinical Neurosciences Networking SeminarClinical Neurosciences Networking Seminar
Clinical Neurosciences Networking Seminar
 
Idiopathic Intracranial Hypertension
Idiopathic Intracranial HypertensionIdiopathic Intracranial Hypertension
Idiopathic Intracranial Hypertension
 
Stroke Made EASY
Stroke Made EASYStroke Made EASY
Stroke Made EASY
 
acute stroke for rehab physician - dr trilochan shrivastava
acute stroke for rehab physician - dr trilochan shrivastavaacute stroke for rehab physician - dr trilochan shrivastava
acute stroke for rehab physician - dr trilochan shrivastava
 
Hemiplegia stroke
Hemiplegia strokeHemiplegia stroke
Hemiplegia stroke
 
ASSESSMENT AND PLANNING GUIDE FOR USE IN THE HOSPITALThe followi.docx
ASSESSMENT AND PLANNING GUIDE FOR USE IN THE HOSPITALThe followi.docxASSESSMENT AND PLANNING GUIDE FOR USE IN THE HOSPITALThe followi.docx
ASSESSMENT AND PLANNING GUIDE FOR USE IN THE HOSPITALThe followi.docx
 
MedReg+1 Bhuva ECGs
MedReg+1 Bhuva ECGsMedReg+1 Bhuva ECGs
MedReg+1 Bhuva ECGs
 

Último

Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communicationskatiequigley33
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerSherrylee83
 
Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfDermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfniloofarbarzegari76
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Ayman Seddik
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale nowSherrylee83
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptxSabbu Khatoon
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)Monika Kanwar
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDr.shiva sai vemula
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptxclaviclebrown44
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumassuser144901
 
PREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptxPREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptxPupayumnam1
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadNephroTube - Dr.Gawad
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...marcuskenyatta275
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxSergio Pinski
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenRaju678948
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxSamar Tharwat
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadNephroTube - Dr.Gawad
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxpalsonia139
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1DR SETH JOTHAM
 

Último (20)

Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfDermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdf
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
PREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptxPREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptx
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 

Stroke thrombolysis Dr Sanjay Jaiswal,consultant nerologist,Jaiswal Hospital and neuro institute,kota,Rajasthan,India

  • 1. THROMBOLYSIS IN ACUTE ISCHEMIC STROKE Experience at our stroke unit in 2011-2012 DR Sanjay Jaiswal, D.MDR Sanjay Jaiswal, D.M Member World Stroke OrganizationMember World Stroke Organization Senior Consultant Neurologist &Senior Consultant Neurologist & Stroke NeurophysicianStroke Neurophysician Jaiswal Hospital and Neuro Institute, KOTAJaiswal Hospital and Neuro Institute, KOTA
  • 2. OutlinesOutlines  The burden of disease & Stroke FactsThe burden of disease & Stroke Facts  PathophysiologyPathophysiology  Stroke mimicsStroke mimics  Pre thrombolysis work up.Pre thrombolysis work up.  Safety and efficacy of IVSafety and efficacy of IV t PA .t PA .  Inclusion and Exclusion criteria's.Inclusion and Exclusion criteria's.  How Tpa is administered.How Tpa is administered.  Time frame (Door to needle time)Time frame (Door to needle time)  Our stroke teamOur stroke team
  • 3. THE BURDEN OF STROKE  Anually more than 15 million people world wideAnually more than 15 million people world wide suffer a stroke, 5.5 million die and 5 million are leftsuffer a stroke, 5.5 million die and 5 million are left with permanent disability.with permanent disability.  Stroke is 2nd most common cause of death.Stroke is 2nd most common cause of death.  In India 1.5million people suffer from Acute StrokeIn India 1.5million people suffer from Acute Stroke every year.every year.  1880 people die every day in India due to1880 people die every day in India due to strokestroke
  • 4.  World wide some one dies of stroke every 6World wide some one dies of stroke every 6 seconds.seconds.  Every two second some one some where inEvery two second some one some where in world suffers from stroke.world suffers from stroke.  Stroke kills more people each year than AIDS,Stroke kills more people each year than AIDS, TB, and Malaria put together.TB, and Malaria put together.  Incidence of stroke is increasing in India andIncidence of stroke is increasing in India and other developing countriesother developing countries
  • 5. Stroke Facts  80 % of strokes are Ischemic .80 % of strokes are Ischemic .  Only 15 % of stroke patients reach inOnly 15 % of stroke patients reach in hospital within 3 hrs.hospital within 3 hrs.  1-5% are thrombolysed1-5% are thrombolysed
  • 6. Reasons for lack of thrombolysis 1. Patient’s inability to recognize stroke symptoms.  40% of stroke patients can’t name a single symptom40% of stroke patients can’t name a single symptom of stroke.of stroke.  85% of patients believe that their symptoms are not85% of patients believe that their symptoms are not serious enough to seek urgent treatment.serious enough to seek urgent treatment. 2. Physician’s lack of experience with stroke thrombolysis and therefore reluctance to “risk” treatment 3. Lack of organized delivery of care in most of the medical centers throughout the country.
  • 7. Nandigram et al 2003  Observed lack of knowledge regarding strokeObserved lack of knowledge regarding stroke thrombolysis among medical professionals inthrombolysis among medical professionals in india.india.  Significant majority of the GPs were not awareSignificant majority of the GPs were not aware of the beneficial effects of thrombolysis.of the beneficial effects of thrombolysis.
  • 8.
  • 9.
  • 10. CASE 1CASE 1  76 Yr old Retired Head Master, relative of a doctor.76 Yr old Retired Head Master, relative of a doctor.  No H/O HTN, DM,CADNo H/O HTN, DM,CAD  Presented with H/O Acute onset Rt hemiparesis withPresented with H/O Acute onset Rt hemiparesis with difficulty in walking independently at 6.30 PM ,wasdifficulty in walking independently at 6.30 PM ,was brought on wheel chair.brought on wheel chair.  Reached to our hospital at 7.50 PM.Reached to our hospital at 7.50 PM.  CT head –No e/o hemorrhage ,haematological investCT head –No e/o hemorrhage ,haematological invest done. Clinical work up completed. by 9.00 PM.done. Clinical work up completed. by 9.00 PM.
  • 11.
  • 12.  Consent received at 10 .00 PM ( 1 hour wasted byConsent received at 10 .00 PM ( 1 hour wasted by relatives in giving consent )relatives in giving consent )  Thrombolysis started at 10.00 PMThrombolysis started at 10.00 PM  Motor power started improving during thrombolysis.Motor power started improving during thrombolysis.  In 24 hrs pt was able to walk with little support.In 24 hrs pt was able to walk with little support.  Discharged on 6 day with mild Neurodeficit.Discharged on 6 day with mild Neurodeficit.  A doctor who is relative of the patient playedA doctor who is relative of the patient played important role in explaining beneficial effects ofimportant role in explaining beneficial effects of thrombolysisthrombolysis
  • 13. CASE 2  76 Yr old male F/O a Doctor had stroke.76 Yr old male F/O a Doctor had stroke.  At 8.30 AM had left sided weakness with slurred speech and confusedAt 8.30 AM had left sided weakness with slurred speech and confused state ,not able to walk.state ,not able to walk.  Brought into hospital at 9.30 AM.Brought into hospital at 9.30 AM.  Pt wheeled straight into CT scan.Pt wheeled straight into CT scan.  Pt shifted to stroke unit, IV Line started and blood withdrawn.Pt shifted to stroke unit, IV Line started and blood withdrawn.  k/c HT, CAD, H/O Angioplasty 15 yrs ago, on anti HT +k/c HT, CAD, H/O Angioplasty 15 yrs ago, on anti HT + ASAASA.(missed ASA for 2 days).(missed ASA for 2 days)
  • 14.
  • 15.  Lt UL– Lifting against gravity but weak grip.Lt UL– Lifting against gravity but weak grip.  Lt LL –2- /5, not able to walk independentlyLt LL –2- /5, not able to walk independently  Poor comprehension with dysarthriaPoor comprehension with dysarthria  CT--. No hemorrhage seenCT--. No hemorrhage seen  BP---140/80BP---140/80  RBS– 118 MG%, CBC, PT , APTT- Normal.RBS– 118 MG%, CBC, PT , APTT- Normal.  Option of thrombolysis given to his son.Option of thrombolysis given to his son.  Consent for tPA taken.Consent for tPA taken.
  • 16.  IV tPA started at 11.30 am. (stroke to needle time 3 hrs)IV tPA started at 11.30 am. (stroke to needle time 3 hrs)  By the time infusion was finished , pt became alert and hisBy the time infusion was finished , pt became alert and his motor power improved significantly.motor power improved significantly.  By evening (6 hrs post thrombolysis) pt. was walkingBy evening (6 hrs post thrombolysis) pt. was walking independently and and had normal speech.independently and and had normal speech.  Discharged on 3Discharged on 3rdrd day with no neurodeficit, WITHday with no neurodeficit, WITH COMPLETE RECOVERY.COMPLETE RECOVERY.
  • 17.
  • 18.
  • 19. CASE 3CASE 3  68 Yr old male,68 Yr old male,  k/c HT, CAD, h/o CABG 10 yrs ago, on anti HT + ASA.k/c HT, CAD, h/o CABG 10 yrs ago, on anti HT + ASA.  At 9.30 PM had right sided weakness with slurred speech .At 9.30 PM had right sided weakness with slurred speech .  Rt L/L Power 1-2 /5, Rt UL 3/5, dysarthria+Rt L/L Power 1-2 /5, Rt UL 3/5, dysarthria+  Brought into hospital at 11.00 PM.Brought into hospital at 11.00 PM.  Pt shifted to stroke unit, IV Line started and blood withdrawn.Pt shifted to stroke unit, IV Line started and blood withdrawn.  CT scan head showed no e/o haemorrhage.CT scan head showed no e/o haemorrhage.  Consent for tPA takenConsent for tPA taken
  • 20.  IV- tPA started at 12.30 AM. (stroke to needle time 3 hrs.  During the infusion pt started moving Rt leg. and his grip had improved significantly.  By next morning (6 hrs post thrombolysis) pt was walking independantly and with no dysarthria.  Patient discharged without any neurodeficit.
  • 21. PathophysiologyPathophysiology 2 Million Neurones are lost every minute in the period in which stroke is untreated
  • 22. PathophysiologyPathophysiology  ischemic penumbraischemic penumbra is the area of the brainis the area of the brain surrounding the infarcted core,and is preservedsurrounding the infarcted core,and is preserved by a tenacious supply of blood from collateralby a tenacious supply of blood from collateral vessels.vessels.  This area can be rescued if the occludedThis area can be rescued if the occluded vessel can be reopened up to 3-8 hours fromvessel can be reopened up to 3-8 hours from symptom onsetsymptom onset
  • 23. Cerebral infarct <3hrsCerebral infarct <3hrs Onset Infarct Ischaemic penumbra
  • 24. Cerebral infarct 6hrsCerebral infarct 6hrs Infarct Ischaemic penumbra
  • 25. Cerebral infarct 24hrsCerebral infarct 24hrs Infarct Ischaemic penumbra
  • 26. Penumbrae of Ischemic Stroke  Penumbrae is the target of any reperfusion therapy  The fate of brain tissue depends on  Time  Cerebral blood flow  Occluded arterial flow  Collateral blood flow  Time is brain-We have to act fast to rescue the Penumbrae
  • 27. Stroke MimicsStroke Mimics  SyncopeSyncope  Partial epileptic seizurePartial epileptic seizure with Todd’s paresiswith Todd’s paresis  Migraine attack (aura)Migraine attack (aura)  HypoglycaemiaHypoglycaemia  HysteriaHysteria  IntoxicationIntoxication  HypertensiveHypertensive encephalopathyencephalopathy  SubarachnoidSubarachnoid haemorrhagehaemorrhage  NeuroinfectionNeuroinfection  NeoplasmNeoplasm  Chr SDHChr SDH  Multiple sclerosisMultiple sclerosis  Peripheral vertigoPeripheral vertigo
  • 28. Hyperacute Stroke: Modern Approach of Tt  Aim: Revascularization of penumbraAim: Revascularization of penumbra  Break down Clot!Break down Clot!  Methods: IV, IA, MechanicalMethods: IV, IA, Mechanical ThrombolysisThrombolysis  Most practical, with proven efficacy atMost practical, with proven efficacy at place like KOTA : IV thrombolysis withplace like KOTA : IV thrombolysis with TPA.TPA.
  • 29. Time is BrainTime is Brain
  • 30. Pre thrombolysis work upPre thrombolysis work up  Should be individualizedShould be individualized  All Pts must have emergently :All Pts must have emergently : 1.1. NCCT BRAINNCCT BRAIN 2.2. ECGECG 3.3. CBC,Plat count, B groupCBC,Plat count, B group 4.4. B GlucoseB Glucose 5.5. Coagulation-PT with INR,APTTCoagulation-PT with INR,APTT 6.6. Other metabolic tests-RFT, LFT, etcOther metabolic tests-RFT, LFT, etc
  • 31. NCCT BRAIN  Initial imaging modality in hyper ac stroke  Widely available, quick, easy to perform  Accurately identifies ICH,SAH EARLY SIGNS OF CEREBRAL ISCHAEMIA  Hyper dense MCA artery sign  Hyper dense dot sign  Hypo density of insular ribbon  Hypoensity of basal ganglia  loss of grey white matter differentiation in cortical ribbon  sulcal effacement EARLY SIGNS ARE ASSOCIATED WITH POORER OUTCOMES
  • 32. Left and middle: Hyperdense left MCA sign (yellow arrow), hypoattenuated left basal ganglia (red arrow), and cortical swelling (blue arrows) in the same patient. Right: Dot sign (yellow arrow) in the left sylvian fissure. Early CT signs in acute MCAEarly CT signs in acute MCA strokestroke
  • 33. NIHSS SCORENIHSS SCORE  NIHSS SCORING CAN BE PERFORMEDNIHSS SCORING CAN BE PERFORMED IN 7 MINUTES .IN 7 MINUTES .  ESSENTIAL TO BE CALCULATEDESSENTIAL TO BE CALCULATED PREDICTOR OF STROKE OUTCOME ANDPREDICTOR OF STROKE OUTCOME AND USED AS A EXCLUSION CRITERIAUSED AS A EXCLUSION CRITERIA ..
  • 34.
  • 35.
  • 36. Inclusion CriteriaInclusion Criteria  Clinical signs and symptoms consistent withClinical signs and symptoms consistent with stroke.stroke.  Patient last seen normal within 4.5 hrs.Patient last seen normal within 4.5 hrs.  Measurable neurological deficit.Measurable neurological deficit.
  • 37. Exclusion Criteria  Any hemorrhage on neuroimaging.Any hemorrhage on neuroimaging.  Symptoms s/o SAH.Symptoms s/o SAH.  Seizure at stroke onset with post ictal neurol deficit.Seizure at stroke onset with post ictal neurol deficit.  Hypodensity greater than 1/3 cerebral hemisphere onHypodensity greater than 1/3 cerebral hemisphere on CT.CT.  SBP>185 & DBP>110SBP>185 & DBP>110  RBS <50 or > 400 mg%RBS <50 or > 400 mg%  Stroke with major neurol deficits-NIHS >22.Stroke with major neurol deficits-NIHS >22.  Minor/isolated/spontaneously clearing neurol signs.Minor/isolated/spontaneously clearing neurol signs.
  • 38. Exclusion Criteria  Platelet count <1 lac/mm3Platelet count <1 lac/mm3  INR>1.7INR>1.7  Elevated APTT.Elevated APTT.  Past h/o ICHPast h/o ICH  Arterial puncture at non compressible site in 7 days.Arterial puncture at non compressible site in 7 days.  Major surgery in past 14 days.Major surgery in past 14 days.  GI bleed or hematuria in past 21 days.GI bleed or hematuria in past 21 days.  Ischemic stroke, Myocardial infarction or serious headIschemic stroke, Myocardial infarction or serious head trauma in last 3 months.trauma in last 3 months.  Evidence of active bleeding or ac trauma (fracture onEvidence of active bleeding or ac trauma (fracture on exam).exam).
  • 39. Stroke Thrombolysis at 3-4.5 Hrs additional Exclusion Criterias  Age >80 yearsAge >80 years  On oral anticoagulants regardless of INROn oral anticoagulants regardless of INR  NIHSS of >25 (Severe stroke)NIHSS of >25 (Severe stroke)  History of both stroke and diabetes.History of both stroke and diabetes.
  • 40. I.VI.V t PAt PA :: Safety and efficacySafety and efficacy Evidence for tPA < 3Evidence for tPA < 3 HoursHours
  • 41. NINDS t PA stroke trial(1995)  NEJM 95:333,1581-87NEJM 95:333,1581-87  624 patients randomized624 patients randomized  3 hour window3 hour window At three months 30% more likelyAt three months 30% more likely to have minimal or no disabilityto have minimal or no disability  6.4% risk of hemorrhage6.4% risk of hemorrhage
  • 42. NINDS tPA Stroke Trial 0 10 20 30 0 10 20 30 tPA tPAPlacebo Placebo 31 20 9 8 20 1 NIHSS Excellent Recovery (%) Total Death Rate (%) Hemorrhage p < .05 New England Journal, 1995
  • 43. NINDS TPA Stroke Trial Global outcome statistic: OR=1.7, 50% v. 38%= 12% benefit Excellent outcome at 3 months on all scales 52% 38% 43% 26% 45% 31% 34% 21% 0% 10% 20% 30% 40% 50% 60% Barthel Index Rankin Scale Glasgow Outcome NIHSS score TPA Placebo N Engl J Med 1995;333:1581-7
  • 44. Time is brain( EARLIER THE BETTER) benefit from rt- PA declines with increasing delay from onset to treatment time Benefit Harm 3 hours 6 hours Upper and lower 95% confidence limits Line of no effect IST-3 protocol
  • 45. For every 100 patients treated withFor every 100 patients treated with t PAt PA ,, 32 benefit, 3 harmed32 benefit, 3 harmed Saver JL et al , Stroke 2007; 38:2279-2283 better outcome by 1 or more grades on the mRS
  • 46.
  • 47. Stroke Thrombolysis: Thrombolytic therapy must be given byThrombolytic therapy must be given by an experienced physicianan experienced physician after theafter the imaging of the brain is assessed byimaging of the brain is assessed by physicians experienced in reading thephysicians experienced in reading the imaging studyimaging study22 1: Hacke W et al.: Lancet (2004) 363:768-74 2: Wahlgren N et al.: Lancet (2007) 369:275-82
  • 48. Stroke Thrombolysis:Stroke Thrombolysis: Evidence forEvidence for t PAt PA at 3 – 4.5at 3 – 4.5 hrshrs
  • 49.
  • 50.
  • 51.
  • 52. Time is Brain :Time is Brain : NINDS Recommended Stroke EvaluationNINDS Recommended Stroke Evaluation Targets for Potential Thrombolytic CandidatesTargets for Potential Thrombolytic Candidates Target time framesTarget time frames Door to doctorDoor to doctor 10 minutes10 minutes Door to CT completionDoor to CT completion 25 minutes25 minutes Door to CT readingDoor to CT reading 45 minutes45 minutes Door to drug treatmentDoor to drug treatment 60 minutes60 minutes
  • 53. How to administer IV t PA  Infuse 0.9mg/kg(max 90 mg ) over 60 mnts with 10 % ofInfuse 0.9mg/kg(max 90 mg ) over 60 mnts with 10 % of the dose given as bolus over 1 mnt.the dose given as bolus over 1 mnt.  Admit pt in neuro ICU or stroke unit.Admit pt in neuro ICU or stroke unit.  Perform neurological assessment every 15 mnts duringPerform neurological assessment every 15 mnts during the infusion and every 30 mnts thereafter for next 6 hoursthe infusion and every 30 mnts thereafter for next 6 hours then hourly until 24 hours after treatment.then hourly until 24 hours after treatment.  If pt develop severe headache,ac HTN, nausea,orIf pt develop severe headache,ac HTN, nausea,or vomitting discontinue infusion and obtain emergency CTvomitting discontinue infusion and obtain emergency CT scan.scan.  AngioedemaAngioedema
  • 54.
  • 55. Risk of hemorrhagic transformation  MarkedMarked hyperglycemia orhyperglycemia or DMDM  CT >1/3CT >1/3 cerebralcerebral hemispherehemisphere  Increasing strokeIncreasing stroke severityseverity  Low platelet countsLow platelet counts  Higher NIHSS scoreHigher NIHSS score  Longer time toLonger time to recanalizationrecanalization ~ Stroke. 2002~ Stroke. 2002
  • 56. If intracranial hemorrhage present:  Obtain fibrinogen results.Obtain fibrinogen results.  Prepare for administration of 6 to 8 units of cryoprecipitatePrepare for administration of 6 to 8 units of cryoprecipitate containing factor VIII.containing factor VIII.  Prepare for administration of 6 to 8 units of platelets.Prepare for administration of 6 to 8 units of platelets.  Consider alerting and consulting a hematologist orConsider alerting and consulting a hematologist or neurosurgeon.neurosurgeon.  Consider decision regarding further medical and/or surgicalConsider decision regarding further medical and/or surgical therapy.therapy.  Consider second CT to assess progression of intracranialConsider second CT to assess progression of intracranial hemorrhage.hemorrhage.  A plan for access to emergent neurosurgical consultation isA plan for access to emergent neurosurgical consultation is highly recommended.highly recommended.
  • 57.
  • 58.
  • 59. Acute Ischemic Stroke Protocol ER arrival Triage nurse confirm stroke onset time < 4.5 hours ER Resident performs Rapid evaluation (5 minutes) 1.exact time of onset 2.important history 3.quick neurological evaluation STAT CT and blood work Neurology Resident receives ER stroke page and proceeds to ER brief history & physical exam Page Stroke consultant Head CT findings, laboratory data, NIH stroke scale Confirm the criteria fulfilling thrombolytic therapy for ischemic stroke Family’s agreement for thrombolytic therapy Stroke onset < 4.5 hours IV-tPA treatment Patient is admitted to Stroke ICU for intensive monitoring/care Stroke onset 4.5-8 hours IA t therapy /device Call Neuroradiologists IA thrombolysis/device
  • 60.  11STST Case tPA given in 3.30 hrs.Case tPA given in 3.30 hrs.  22ndnd Case tPA given in 3 hrs.Case tPA given in 3 hrs.  33rdrd Case tPA given in 3 hrsCase tPA given in 3 hrs  All made excellent recovery.All made excellent recovery.  Earlier protocol ---Earlier protocol --- window period -- 3hrs.window period -- 3hrs.  Latest ECASS 3 trial---Latest ECASS 3 trial--- window period extended upto 4.5 hrs.window period extended upto 4.5 hrs.
  • 61. OUR STROKE TEAM  NeurologistNeurologist  NeurosurgeonNeurosurgeon  IntensivistIntensivist  NeuroradiologistNeuroradiologist  NeuropathologistNeuropathologist  NeurophysiotherepistNeurophysiotherepist  RMOS,Techs,Trained staffRMOS,Techs,Trained staff
  • 62. TAKE HOME MESSAGE  IV r TPA IS RECOMMENDEDIV r TPA IS RECOMMENDED THEREPY FOR SELECTED PATIENTSTHEREPY FOR SELECTED PATIENTS WHO REACH HOSPITAL WITHIN 4.5WHO REACH HOSPITAL WITHIN 4.5 HOURS OF STROKE ONSET.HOURS OF STROKE ONSET.  Thrombolysis is possible in kota.Thrombolysis is possible in kota.  Need to rush from bed to bedside.Need to rush from bed to bedside.
  • 63. TAKE HOME MESSAGETAKE HOME MESSAGE  At 3 months 30% more likely to have minimalAt 3 months 30% more likely to have minimal or no disability following thrombolysis.or no disability following thrombolysis.  There should be no protocol violation otherThere should be no protocol violation other wise more complications.wise more complications.  We have to increase awareness among patients,We have to increase awareness among patients, general public and doctors regarding beneficialgeneral public and doctors regarding beneficial effects of stroke thrombolysis.effects of stroke thrombolysis.
  • 64. World Stroke day- 29 octoberWorld Stroke day- 29 october WSO Slogan- entitled ‘Because I care..WSO Slogan- entitled ‘Because I care.. Because I care… I want you to know the facts about stroke I want you to learn how to prevent the assault of stroke I will break the myths surrounding stroke, e.g., “stroke only happens later in life” I want you to have access to the best possible treatment I will ensure that you receive quality treatment, care and support I will be with you every step of the way towards your full recovery

Notas del editor

  1. ER Procedure: Differential Diagnosis In stroke patients, clinical features are usually sufficient to enable at least preliminary diagnosis. CT scanning is instrumental in documenting cerebral haemorrhage, neuroinfection or brain injury, but does not help to exclude possibilities such as syncope, partial epileptic seizure with Todd’s paresis, migraine attack with aura, hypoglycaemia, hysteria, intoxication, meningitis or multiple sclerosis. In this context, it is important to remain aware that confirmatory tests should supplement – rather than replace – conventional clinical skills. In practice, the most important distinction is between ischaemic stroke and intracranial haemorrhage. The clinical features of these conditions may overlap, but their treatment is markedly different. 1 Early distinction between the various subtypes of ischaemic stroke is also becoming important (i.e. lacunar vs large artery or cardioembolic stroke), as there is evidence that these may respond differently to different treatments. This is a situation in which neuroimaging techniques such as CT scanning can be invaluable, although clinical scoring systems based on the presence or absence of specific clinical features can also be strongly predictive. One such system – the Allen score – has been found to be 90% accurate in the identification of haemorrhage. 2–4 References 1. European Ad Hoc Consensus Group. European strategies for early intervention in stroke: a report of an Ad Hoc Consensus Group meeting. Cerebrovasc Dis 1996; 6: 315–24. 2. Allen CMC. Clinical diagnosis of the acute stroke syndrome. Q J Med 1984; 208: 515–23. 3. Sandercock PAG, Allen CMC, Corston RN et al. Clinical diagnosis of intracranial haemorrhage using Guy’s hospital score. Br Med J 1985; 291: 1675–7. 4. Celani MG, Righetti E, Migliacci R et al. Comparability and validity of two clinical scores in the early differential diagnosis of acute stroke. Br Med J 1994 ; 308: 1674–6 27